Key statistics
On Thursday, Metagenomi Inc (MGX:NSQ) closed at 1.82, 13.04% above the 52 week low of 1.61 set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.67 |
---|---|
High | 1.86 |
Low | 1.66 |
Bid | 1.74 |
Offer | 1.91 |
Previous close | 1.65 |
Average volume | 628.48k |
---|---|
Shares outstanding | 37.46m |
Free float | 26.68m |
P/E (TTM) | -- |
Market cap | 68.18m USD |
EPS (TTM) | -2.51 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
- Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
- Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
- Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
- Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
- Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
- Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
- Metagenomi to Participate in Upcoming Investor Conferences
- Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
- Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
More ▼